Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FR9VD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,694
Award facts
- Contract value 100% obligated
- $27,693.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,693.94 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packs (30 count) on September 17, 2025, with completion targeted for October 8, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense Logistics Agency's medical supply chain and holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026 designated as SPE2DX with DLA Troop Support Medical.
This delivery order is issued under AmerisourceBergen's broader pharmaceutical prime vendor contract, which enables the company to supply a comprehensive range of medications and medical commodities to support military healthcare programs globally. Vyndamax (tafamidis), used primarily for cardiac amyloidosis treatment, represents one of the specialized medications within the company's extensive portfolio delivered through the DLA Medical Supply Chain to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a child contract to the larger IDC vehicle, this delivery order demonstrates AmerisourceBergen's continued role as a strategic pharmaceutical distributor for federal defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FR9VD?
SPE2DB25FR9VD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FR9VD worth?
The government has obligated $27,694 on SPE2DB25FR9VD.
Is contract SPE2DB25FR9VD an order under another contract?
Yes. SPE2DB25FR9VD is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9VD competed?
The extent of competition for SPE2DB25FR9VD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award